🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting news! This Sunday marks the start of the 20th Annual Meeting of the Oligonucleotide Therapeutics Society in Montreal 🇨🇦, and several members of the #HAYA team will be attending. Be sure to stop by our posters to discover more about our innovative approach. 2024oligomeeting.com

We’re excited to share that members of #HAYA team will be attending the BioTechX meeting in Basel next week! If you are attending, let’s connect! We have some exciting opportunities opening soon in computational biology and data science 🤝

In-person brainstorming fuels #creativity & strengthens our #collaboration as a team - especially when includes a ☀️ afternoon on the 🏖️. #HAYA international presence is a commitment to attract the #BestTalent and foster a #GlobalTeam that that drives our mission forward 🚀

🚀 We're Hiring! We are seeking visionary and motivated individuals to join #HAYATherapeutics team. New Open Positions: #Biomarker_CompSci 🧪💻 #Senior_Bioinfo 💻 #Sci_RNABio_MetD 🧬🔬 #RA 🔬 ➡️ Apply TODAY: hayatx.com/careers Follow us, new positions are opening soon🤝

✈️ We’re just 1-week away from the #FallInternationalConvention of the #PharmaceuticalSocietyofKorea! Join us for an exciting presentation by HAYA's Dir. Biology & Funct. Genomics, rudi micheletti! Seize this opportunity to learn more about #HAYA!🧬 ➡️shorturl.at/02pBn

Are you attending the #HCMSummit8? Connect with Jordan Shin, #HAYA’s CMO & visit us at exhibit table 12 to learn more about HTX-001, a novel #AntifibroticAgent with a complementary approach to current background therapies aimed at treating #HCM.🫀 ➡️shorturl.at/c5fuD

🚀 We're Hiring! We are seeking visionary and motivated individuals to join #HAYATherapeutics team. New Open Positions: #Scientist_Biomarker🧪 #Admin_Assistant 💻 ➡️Apply TODAY: hayatx.com/careers#sectio… LinkedIN Jobs🤝

Join #HAYA, CEO Samir Ounzain this Halloween🎃 at @fci_health for a lecture on “Unlocking the #RegulatoryGenome: Pioneering RNA-guided therapeutics for cell-state modulation in disease pathogenesis”. 🧬 🗓️October 31, at 11h CET 📍GSH Lecture Hall Learn more: shorturl.at/KdM5W

🚀Last week, we welcomed Carsten Merkwirth as #HAYA's Senior Director, #Biomarkers. We are thrilled to start working with him to help us develop & implement biomarker strategies across HAYA’s pipeline.🎉 Learn more at: shorturl.at/Fe39P

🚀 Targeting #RegulatoryGenome RNAs to #Reprogram Disease #CellStates - The #HAYA Way to Fight Disease 👉🏻We invite you to learn more about us in our profile article at Biopharma Dealmakers : nature.com/articles/d4374…

We are one week away of the #DGS2024 , and we are thrilled to be part of it!🧬 Join #HAYA team at the poster session to discover how we are leveraging the #DarkGenome to develop #medicines capable to promote #PartialCellReprogramming. Samir Ounzain

🚀 #HAYA CEO, Samir Ounzain had an insightful conversation with Daniel Levine for #theBioReport podcast about how the “#darkmatter” of the human genome can be key to developing #noveltherapies with the potential address the root causes of diseases! 🎧 Listen to learn more! Levine Media Group

🎙️Another Podcast, Another Insight! 🎙️ In the latest episode of the swisspreneur podcast, HAYA's CEO & co-founder, Samir Ounzain dives into his career path, the foundation and future of #HAYA!🚀 🎧 Listen to learn more: swisspreneur.org/podcast/samir-…

🚀 Pioneering a transformative breakthrough in disease treatment, HAYA Therapeutics aims to reshape patient care by harnessing the potential of Dark Genome-derived RNAs to reprogram diseased cells back to a healthy state. 🧬 innosuisse.admin.ch/en/putting-inn…

🚀 We’re beyond excited to share that #HAYA has been recognized by the Innosuisse as one of their #SuccessStories! 🌟 Innosuisse plays a pivotal role in the 🇨🇭start-up ecosystem, and has provided HAYA with valuable support over the years. ➡️ Learn more: shorturl.at/f91WS

Wishing you a wonderful #HolidaySeason filled with love, laughter, rest and inspiration. 🎁🌟 Happy Holidays from ALL OF US at #HAYATherapeutics!✨ May 2025 be full of great #discoveries and #breakthroughs! 🚀

✈️ Are you attending the Keystone Symposia "#TME: #Metastasis and the Host? Then don’t miss the poster presentation by #HAYA's Project Leader Emely Möller on January 20, at 7:30pm MST.🧬 lnkd.in/eKvXGWNi Looking forward to meeting you in Banff! 🤝

📣 Today, we are thrilled to welcome Rich Law as #HAYATherapeutics’ #CBO! Looking forward to the future ahead of us. Stay tuned for more exciting news! lnkd.in/eMVFw_8E Welcome to the team Richard!🎉

📣 #MDs: This One’s for You! #HAYA is building its clinical dev. function—and we’re looking for a #SeniorMedicalDir! If you want to be among the team who are driving first-in-class #lncRNA-targeting therapies for #HCM , this is your moment. 🫀 ➡️shorturl.at/3bOEq

🚀 We're thrilled to announce that #HAYATherapeutics have successfully raised $65Million in #SeriesA round of financing 🎉 A huge #THANKYOU to our TEAM, PARTNERS, and INVESTORS! 🙌 ➡️hayatx.com/news Sofinnova Partners Earlybird VC